Tempo Therapeutics, Inc. — Form D
Tempo Therapeutics, Inc. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2020-06-02. The offering totals $3.9M, of which $3.8M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2020-06-02
- Form: D
- Accession: 0001813688-20-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $3.9M
- Amount sold: $3.8M
- Remaining: $54K
- Investors: 39
- Date of first sale: 2020-05-21
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-368077
Issuer
- Name: Tempo Therapeutics, Inc.
- CIK: 0001813688
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 3030 BUNKER HILL STREET, SAN DIEGO, CA, 92109
- Phone: (251) 654-4070
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| Biren Mehta | Director | DALLAS, TX |
| Richard Hancock | Director | SAN DIEGO, CA |
| Donald Griffin | Director | SAN DIEGO, CA |
| Steven Richieri | Director | SAN DIEGO, CA |
| Steven Richieri | Executive Officer | SAN DIEGO, CA |
| Robin Sitver | Director | SAN DIEGO, CA |
| Steven Sands | Director | New York, NY |
| Westbrook Weaver | Director | SAN DIEGO, CA |
| Westbrook Weaver | Executive Officer | SAN DIEGO, CA |
| Westbrook Weaver | Promoter | SAN DIEGO, CA |
| Dino Di Carlo | Director | Los Angeles, CA |
Other filings by this issuer (2)
More